EP Patent

EP0005768A1 — Pharmaceutical formulations containing prostaglandin compounds and method for their preparation

Assigned to Wellcome Foundation Ltd · Expires 1979-12-12 · 46y expired

What this patent protects

Stabilised pharmaceutical formulations of prostacyclin or certain analogues thereof comprising an amino acid buffer, optionally containing a base, and the preparation of such formulations.

USPTO Abstract

Stabilised pharmaceutical formulations of prostacyclin or certain analogues thereof comprising an amino acid buffer, optionally containing a base, and the preparation of such formulations.

Drugs covered by this patent

Patent Metadata

Patent number
EP0005768A1
Jurisdiction
EP
Classification
—
Expires
1979-12-12
Drug substance claim
No
Drug product claim
No
Assignee
Wellcome Foundation Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.